β-secretase (BACE) and GSK-3 mRNA levels in Alzheimer's disease

被引：55

作者：

Preece, P

Virley, DJ

Costandi, M

Coombes, R

Moss, SJ

Mudge, AW

Jazin, E

Cairns, NJ

机构：

[1] Quantuum, Dept Neurol, La Coruna 15177, Galicia, Spain

[2] Glaxo SmithKline Pharmaceut, Dept Neurosci, Harlow CM19 5AW, Essex, England

[3] Guys Hosp, Kings Coll London, MRC Ctr Dev Neurobiol, London SE1 1UL, England

[4] UCL, MRC Lab Mol & Cellular Biol, London WC1E 6BT, England

[5] Uppsala Univ, Rudbeck Lab, Dept Med Genet, S-75185 Uppsala, Sweden

[6] Uppsala Univ, Rudbeck Lab, Dept Pathol, S-75185 Uppsala, Sweden

[7] Univ Penn, Sch Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA

来源：

MOLECULAR BRAIN RESEARCH | 2003年 / 116卷 / 1-2期

关键词：

Alzheimer's disease; human brain; mRNA; quantification; TaqMan; BACE; GSK-3;

D O I：

10.1016/S0169-328X(03)00233-X

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

beta-Secretase (BACE) and glycogen synthase kinase (GSK 3) are two enzymes thought to play a role in Alzheimer's disease. We extracted mRNA from 90 Alzheimer and 81 control brains. Levels of mRNA were quantified for BACE and GSK 3 with TaqMan(TM) real-time RT-PCR. We found no change in the Alzheimer's disease brains relative to controls for either the BACE or the GSK 3alpha mRNA levels. (C) 2003 Elsevier B.V. All rights reserved.

引用

收藏

页码：155 / 158

页数：4

相关论文

共 37 条

[1] MODULATION OF PHF-LIKE TAU PHOSPHORYLATION IN CULTURED NEURONS AND TRANSFECTED CELLS [J].

ANDERTON, BH ;

BRION, JP ;

COUCK, AM ;

DAVIS, DR ;

GALLO, JM ;

HANGER, DP ;

LADHANI, K ;

LATIMER, DA ;

LEWIS, C ;

LOVESTONE, S ;

MARQUARDT, B ;

MILLER, CCJ ;

MULOT, SFC ;

REYNOLDS, CH ;

RUPNIAK, T ;

SMITH, CJ ;

STABEL, S ;

WOODGETT, J .

NEUROBIOLOGY OF AGING, 1995, 16 (03) :389-397

[2] Expression of β-secretase mRNA in transgenic Tg2576 mouse brain with Alzheimer plaque pathology [J].

Bigl, M ;

Apelt, J ;

Luschekina, EA ;

Lange-Dohna, C ;

Rossner, S ;

Schliebs, R .

NEUROSCIENCE LETTERS, 2000, 292 (02) :107-110

[3] The quantification of gene expression in an animal model of brain ischaemia using TaqMan™ real-time RT-PCR [J].

Bond, BC ;

Virley, DJ ;

Cairns, NJ ;

Hunter, AJ ;

Moore, GBT ;

Moss, SJ ;

Mudge, AW ;

Walsh, FS ;

Jazin, E ;

Preece, P .

MOLECULAR BRAIN RESEARCH, 2002, 106 (1-2) :101-116

[4] Levels of β-secretase BACE and α-secretase ADAM10 mRNAs in Alzheimer hippocampus [J].

Gatta, LB ;

Albertini, A ;

Ravid, R ;

Finazzi, D .

NEUROREPORT, 2002, 13 (16) :2031-2033

[5] TAU-PROTEIN AND THE NEUROFIBRILLARY PATHOLOGY OF ALZHEIMERS-DISEASE [J].

GOEDERT, M .

TRENDS IN NEUROSCIENCES, 1993, 16 (11) :460-465

[6] MOLECULAR DISSECTION OF THE PAIRED HELICAL FILAMENT [J].

GOEDERT, M ;

SPILLANTINI, MG ;

JAKES, R ;

CROWTHER, RA ;

VANMECHELEN, E ;

PROBST, A ;

GOTZ, J ;

BURKI, K ;

COHEN, P .

NEUROBIOLOGY OF AGING, 1995, 16 (03) :325-334

[7]

GRIFFIN WST, 1993, BIOL PATHOLOGY ASTRO

[8] GLYCOGEN-SYNTHASE KINASE-3 INDUCES ALZHEIMERS DISEASE-LIKE PHOSPHORYLATION OF TAU - GENERATION OF PAIRED HELICAL FILAMENT EPITOPES AND NEURONAL LOCALIZATION OF THE KINASE [J].

HANGER, DP ;

HUGHES, K ;

WOODGETT, JR ;

BRION, JP ;

ANDERTON, BH .

NEUROSCIENCE LETTERS, 1992, 147 (01) :58-62

[9] Increased expression of the amyloid precursor β-secretase in Alzheimer's disease [J].

Holsinger, RMD ;

McLean, CA ;

Beyreuther, K ;

Masters, CL ;

Evin, G .

ANNALS OF NEUROLOGY, 2002, 51 (06) :783-786

[10] Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3 [J].

Hong, M ;

Chen, DCR ;

Klein, PS ;

Lee, VMY .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (40) :25326-25332

← 1 2 3 4 →